An exploration of how targeted nanoparticles and artificial intelligence algorithms combine to locate prostate cancer earlier ...

KPG-121, a novel cereblon modulator, in patients with metastatic castration resistant prostate cancer: Results of a phase I multiple ascending dose study. Baseline PSMA PET/CT as a predictive ...

Researchers at Queen Mary University of London have found that the likelihood of prostate cancer overdiagnosis—the detection ...

A research team at Osaka University will start an investigator-initiated clinical trial for refractory prostate cancer patients after successful development of a new alpha-ray therapeutic agent ...

Prostate cancer screening is essential for early detection, especially in high-risk groups like men over 50, African Americans, and those with a family history. Routine screening, including PSA tests ...

About The Study: This population-based cohort study of men with prostate cancer suggests that higher county-level prevalence of prostate-specific antigen (PSA) screening was associated with lower odds ...

A new report in JAMA Network Open reports on factors associated with prostate cancer screening among transgender women. Not much is known about the incidence of prostate cancer in this population, but ...

Health officials are exploring a “single, trusted national home-testing capability” that focuses on seven areas of medicine.

Patients could be asked to test at home for prostate-specific antigen (PSA) and cholesterol levels, among other tests.

Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. This voice experience is generated by AI. Learn more. This voice ...